This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Copenhagen. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Filip Krag Knop: Innovator in Peptide Analogues
Introduction
Filip Krag Knop is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of peptide analogues that have potential therapeutic applications.
Latest Patents
His most recent patent focuses on glucose-dependent insulinotropic polypeptide (GIP)-derived peptide analogues. The patent, which includes GIP(3-30), outlines their use as antagonists of the GIP receptor. These analogues are particularly relevant for the treatment of disorders such as obesity, diabetes mellitus, and insulin resistance. Filip holds 1 patent in this area.
Career Highlights
Filip is affiliated with the University of Copenhagen, where he conducts research and develops innovative solutions in the field of peptide chemistry. His work is instrumental in advancing our understanding of metabolic disorders and their treatment.
Collaborations
He collaborates with esteemed colleagues, including Alexander Hovard Sparre-Ulrich and Mette Marie Rosenkilde, to further enhance the impact of his research.
Conclusion
Filip Krag Knop's contributions to the field of peptide analogues represent a significant advancement in the treatment of metabolic disorders. His innovative work continues to pave the way for future research and therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile